
Maczone XP 250mg/31.25mg Injection
Marketer
Macleods Pharmaceuticals Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Maczone XP 250mg/31.25mg Injection
Combiflox 250 mg/31.25 mg Injection, a dual-action antibiotic, combats diverse bacterial infections. Its mechanism prevents microbial proliferation and infection spread. Administration must be under a doctor's direct guidance; strict adherence to the prescribed dosage schedule is crucial for optimal efficacy. Premature cessation may compromise treatment effectiveness. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Severe or persistent side effects necessitate immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) require prompt emergency care. Inform your physician of all current medications, including those for pre-existing conditions, before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving is discouraged if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration are vital for recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Maczone XP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Maczone XP 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Maczone XP 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Maczone XP 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Maczone XP 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactum injection (Maczone XP 250 mg/31.25 mg) unites a cephalosporin antibiotic with a beta-lactamase inhibitor. Ceftriaxone's antibacterial action arises from its disruption of bacterial cell wall synthesis, hindering their growth and survival. Tazobactum, conversely, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Maczone XP 250 mg/31.25 mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Maczone XP 250 mg/31.25 mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, clinical data from human subjects remain scarce.
Breast feedingCAUTION
Administering Maczone XP 250 mg/31.25 mg Injection to breastfeeding mothers requires careful consideration. Discontinue breastfeeding throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Maczone XP 250 mg/31.25 mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from driving if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Maczone XP 250 mg/31.25 mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Maczone XP 250 mg/31.25 mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Maczone XP 250 mg/31.25 mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Maczone XP 250mg/31.25mg Injection :
Omitting a scheduled dose of Maczone XP 250 mg/31.25 mg Injection warrants immediate physician consultation.
Facts to Know About Maczone XP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
